Criteria for the behavioral variant of frontotemporal dementia (bvFTD) include decreased frontal metabolism. FDG-PET was used to investigate whether patients with neurocognitive disorder and behavioral disturbance (bvNCD) who did not fulfill three bvFTD criteria had characteristic brain metabolic pattern. Methods: Patients were referred from memory clinic to nuclear medicine for differential diagnosis of NCD with dysexecutive syndrome and predominant mild frontal atrophy. Patients were classified into two groups before FDG-PET, probable bvFTD (n = 25) or bvNCD (n = 27) when only two bvFTD criteria were met. Results: Voxel-based and multivariate PLS analyses of FDG-PET did not show significant between-group difference at inclusion. After 4.8 years of follow-up, most patients with probable bvFTD received the same diagnosis, 3 remained very stable and one participant was given a psychiatric diagnosis. Five patients with bvNCD fulfilled criteria for probable bvFTD at 4.4 years mean follow up, while 2 participants remained very stable and 3 received alternative neurological or psychiatric diagnoses. When initial FDG-PET were compared between groups stratified at follow up (26 bvFTD versus 17 bvNCD), there was a trend (p<.001uncorrected) for lower prefrontal with relatively preserved premotor metabolism in bvFTD compared to bvNCD. Twelve bvNCD participants had neuropsychological testing before inclusion. They all presented executive dysfunction and normal visuospatial performance, and most (n = 9) had memory encoding impairment. Conclusion: Frontal hypometabolism was observed in a dysexecutive presentation of frontal neurodegenerative disorder (bvNCD) that did not fulfill all clinical criteria for bvFTD.
Criteria for the behavioral variant of frontotemporal dementia (bvFTD) include decreased frontal metabolism. FDG-PET was used to investigate whether patients with neurocognitive disorder and behavioral disturbance (bvNCD) who did not fulfill three bvFTD criteria had characteristic brain metabolic pattern. Methods: Patients were referred from memory clinic to nuclear medicine for differential diagnosis of NCD with dysexecutive syndrome and predominant mild frontal atrophy. Patients were classified into two groups before FDG-PET, probable bvFTD (n = 25) or bvNCD (n = 27) when only two bvFTD criteria were met. Results: Voxel-based and multivariate PLS analyses of FDG-PET did not show significant between-group difference at inclusion. After 4.8 years of follow-up, most patients with probable bvFTD received the same diagnosis, 3 remained very stable and one participant was given a psychiatric diagnosis. Five patients with bvNCD fulfilled criteria for probable bvFTD at 4.4 years mean follow up, while 2 participants remained very stable and 3 received alternative neurological or psychiatric diagnoses. When initial FDG-PET were compared between groups stratified at follow up (26 bvFTD versus 17 bvNCD), there was a trend (p<.001uncorrected) for lower prefrontal with relatively preserved premotor metabolism in bvFTD compared to bvNCD. Twelve bvNCD participants had neuropsychological testing before inclusion. They all presented executive dysfunction and normal visuospatial performance, and most (n = 9) had memory encoding impairment. Conclusion: Frontal hypometabolism was observed in a dysexecutive presentation of frontal neurodegenerative disorder (bvNCD) that did not fulfill all clinical criteria for bvFTD.
Authors: Perminder S Sachdev; Deborah Blacker; Dan G Blazer; Mary Ganguli; Dilip V Jeste; Jane S Paulsen; Ronald C Petersen Journal: Nat Rev Neurol Date: 2014-09-30 Impact factor: 42.937
Authors: Michael C Woodward; Christopher C Rowe; Gareth Jones; Victor L Villemagne; Tammie A Varos Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Claudia Jacova; Ging-Yuek R Hsiung; Itthipol Tawankanjanachot; Katie Dinelle; Siobhan McCormick; Marjorie Gonzalez; Hyunsoo Lee; Pheth Sengdy; Phoenix Bouchard-Kerr; Matthew Baker; Rosa Rademakers; Vesna Sossi; A Jon Stoessl; Howard H Feldman; Ian R Mackenzie Journal: Neurology Date: 2013-09-04 Impact factor: 9.910
Authors: B J Kerklaan; B N M van Berckel; K Herholz; A Dols; W M van der Flier; P Scheltens; Y A L Pijnenburg Journal: Am J Alzheimers Dis Other Demen Date: 2014-02-26 Impact factor: 2.035
Authors: O Lindberg; P Ostberg; B B Zandbelt; J Oberg; Y Zhang; C Andersen; J C L Looi; N Bogdanović; L-O Wahlund Journal: AJNR Am J Neuroradiol Date: 2009-04-03 Impact factor: 3.825